Letosteine
Clinical data | |
---|---|
Trade names | Viscotiol |
Routes of administration | Oral (gastroresistant capsules) |
ATC code | R05CB09 (WHO) |
Identifiers | |
| |
Synonyms | 2-[2-(ethoxycarbonylmethylsulfanyl)ethyl]-1,3-thiazolidine-4-carboxylic acid |
CAS Number | 53943-88-7 |
PubChem (CID) | 68707 |
DrugBank | DB08939 |
ChemSpider | 61958 |
UNII | 6MVF9U95DW |
KEGG | D07380 |
ChEBI | CHEBI:88271 |
ECHA InfoCard | 100.053.509 |
Chemical and physical data | |
Formula | C10H17NO4S2 |
Molar mass | 279.378 g/mol |
3D model (Jmol) | Interactive image |
| |
| |
(what is this?) (verify) |
Letosteine is a mucolytic patented (U.S. patent 6987120) by Piero del Soldato of Milan, Italy.[1] He filed his application in 2000.
References
This article is issued from Wikipedia - version of the 8/13/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.